The value of routine follow-up in secondary care for cancer patients has been widely questioned. Within our network cancer centre for gynaecological malignancies current follow-up protocols have been associated with delays in diagnosing recurrence. The aim of this study was to ascertain general practitioners' (GPs') attitudes and feasibility of randomisation for a pilot randomised controlled trial to evaluate follow-up of patients treated for gynaecological malignancy. There was a 78% response rate to the postal questionnaire; overall, GP attitudes were positive, with randomisation seeming feasible. We await the results from the pilot trial.